NCT01885780已完成4 期
Phase IV Study_Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy Following the Cataract Surgery.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 45
- 试验地点
- 2
- 主要终点
- Keratomic corneal astigmatism
研究概览
简要总结
This clinical phase IV study is an open, prospective phase IV study and acts to evaluate the effectiveness of the femtolaser-assisted astigmatic keratotomy.
详细描述
The purpose of this prospective phase IV study acts to address the predictability and effectiveness of astigmatic keratotomy in eyes after femtolaser-assisted cataract surgery. Within this prospective data collection the laser-assisted Arcuate Incisions are performed by the VICTUS™ Femtosecond Laser Platform.
This study will be conducted at Gemini eye clinic in Zlin, Czech Republic by Dr. Pavel Stodulka who will treat up to 50 eyes. Patients will be recruited according to the study inclusion/exclusion criteria.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Clear corneal media
- •Patients must be at least 40 years of age
- •Mono- or bilateral Cataract treatment
- •Keratometric astigmatism: ≥ 1.0 D and ≤ 3 D
- •Patients must have read, understood the Patient Information and signed the informed consent form
- •Patients are willing and able to return for follow-up examinations
排除标准
- •The maximum K- value may not exceed 60D, the minimal value may not be smaller than 37D
- •Pachymetry data for 7-8 mm zone are not available.
- •Corneal disease or pathology, such as corneal scaring or opacity, that precludes transmission of laser wavelength or that distorts laser light
- •Subjects with a poorly dilating pupil or other defect of the pupil that prevents the iris from adequate retraction peripherally
- •Lens/zonular instability such as, but not restricted to, Marfan's Syndrome, Pseudoexfoliation Syndrome, etc.
- •Manifest Glaucoma
- •Previous intraocular or corneal surgery of any kind, including any type of surgery for either refractive or therapeutic purposes in either eye
- •Known sensitivity to planned concomitant medications
- •Patients regularly taking medicines that could influence the result of the treatment respectively the vision
- •Patients with disorders of the ocular muscle, such as nystagmus or strabismus
- •Patients with keratoconus, keratectasia or other irregular cornea changes
- •Patients with connective tissue weakness
- •Patients who are blind on one eye
- •Subjects who are immune compromised or carrying diagnosis of connective tissue disease, clinically significant atopic disease, insulin dependent diabetes mellitus, autoimmune diseases, ocular herpes zoster or simplex, endocrine diseases, lupus, rheumatoid arthritis, collagenosis and other acute or chronic illnesses that will increase the risk to the subject or confound the outcomes of this study.
- •Abnormal examination results from slit lamp, fundus examination or IOL Master, age related changes are acceptable
- •Patients with eye diseases which decreases the visual acuity such as macular degeneration, macular edema, proliferative diabetic Retinopathy
- •Abnormal examination results from Topography, age related changes are acceptable
- •Patients who are pregnant or nursing
- •Patients with concentration disorders, epilepsy and other complicating diseases
- •Patients who are participating in another clinical study 30 days before
结局指标
主要结局
Keratomic corneal astigmatism
时间窗: The study endpoints will be calculated for the 3-Months follow-up examination.
The postoperative keratomic corneal astigmatism is in 60% of all eyes equal or better than 1.0D
次要结局
- Topographic corneal and subjective cylinder(This end point is measured at the 3 Months Follow Up.)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).Metastatic Colorectal CancerNCT03564938Bayer100
Unknown
不适用
Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid ArthritisRheumatoid ArthritisNCT02528292Barts & The London NHS Trust24
已完成
4 期
Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive KeratectomyPhotorefractive KeratectomyCorneal De-epithelializationNCT04704518Laboratorios Sophia S.A de C.V.96
已完成
4 期
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.Alzheimer's DiseaseNCT02989402Novartis Pharmaceuticals100
进行中（未招募）
4 期
To compare combination of study with marketed other combination of drug in patients having both anxiety and depression.CTRI/2022/11/047050Mankind Pharma Limited